Talk:Samarium (153Sm) lexidronam

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Low	This article has been rated as Low-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Samarium (153Sm) lexidronam.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Structure is probably incorrect

The structure shown is probably incorrect - one would not expect 6-coordinate Sm(III). Probably not important to the biomedical community, but to chemists.--Smokefoot (talk) 12:29, 29 July 2009 (UTC)[reply]

There may be some useful data in doi:10.1007/s10856-008-3426-1, and perhaps doi:10.1517/14656566.7.11.1475. Fvasconcellos (t·c) 01:30, 30 July 2009 (UTC)[reply]

It might be useful to discuss clinical trials and preclinical trials of the drug in order to better understand its development. Lngr222 (talk) 20:09, 11 December 2013 (UTC)lngr222[reply]